ANI PHARMACEUTICALS, INC Other Comprehensive Income (Loss), Net of Tax
ANI PHARMACEUTICALS, INC (ANIP) reported Other Comprehensive Income (Loss), Net of Tax of -$806.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$806.00K.
- ANI PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$554.00K.
- ANI PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was -$1.78M.
- ANI PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was -$501.00K.
- ANI PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for fiscal 2025 was -$4.31M.
- ANI PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for fiscal 2024 was -$3.51M.
- ANI PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for fiscal 2023 was -$3.31M, a 121.75% decline from fiscal 2022.
- ANI PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for fiscal 2022 was $15.22M, a 81.62% increase from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$806.00K 10-Q · filed 2026-08-07 | -$1.36M 10-Q · filed 2026-08-07 | -$3.14M derived: sum of 3 quarters · filed 2026-08-07 | -$3.64M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$554.00K 10-Q · filed 2026-05-08 | -$2.33M derived: sum of 2 quarters · filed 2026-05-08 | -$2.83M derived: sum of 3 quarters · filed 2026-05-08 | -$3.13M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.28M derived: sum of 2 quarters · filed 2026-02-27 | -$2.58M derived: sum of 3 quarters · filed 2026-08-07 | -$4.31M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$501.00K 10-Q · filed 2025-11-07 | -$799.00K derived: sum of 2 quarters · filed 2026-08-07 | -$2.53M 10-Q · filed 2025-11-07 | -$2.56M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$298.00K 10-Q · filed 2026-08-07 | -$2.03M 10-Q · filed 2026-08-07 | -$2.05M derived: sum of 3 quarters · filed 2026-08-07 | -$5.02M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$1.73M 10-Q · filed 2026-05-08 | -$1.76M derived: sum of 2 quarters · filed 2026-05-08 | -$4.72M derived: sum of 3 quarters · filed 2026-05-08 | -$5.80M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.98M derived: sum of 2 quarters · filed 2026-02-27 | -$4.06M derived: sum of 3 quarters · filed 2026-02-27 | -$3.51M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$2.96M 10-Q · filed 2025-11-07 | -$4.04M derived: sum of 2 quarters · filed 2025-11-07 | -$3.49M 10-Q · filed 2025-11-07 | -$8.71M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$1.08M 10-Q · filed 2025-08-08 | -$529.00K 10-Q · filed 2025-08-08 | -$5.75M derived: sum of 3 quarters · filed 2026-02-27 | -$5.40M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $549.00K 10-Q · filed 2025-05-09 | -$4.67M derived: sum of 2 quarters · filed 2026-02-27 | -$4.32M derived: sum of 3 quarters · filed 2026-02-27 | -$1.73M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$4.87M derived: sum of 2 quarters · filed 2026-02-27 | -$2.27M derived: sum of 3 quarters · filed 2026-02-27 | -$3.31M 10-K · filed 2026-02-27 |
| 2023-09-30 | $350.00K 10-Q · filed 2024-11-08 | $2.94M derived: sum of 2 quarters · filed 2024-11-08 | $1.91M 10-Q · filed 2024-11-08 | $4.04M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $2.60M 10-Q · filed 2024-08-06 | $1.56M 10-Q · filed 2024-08-06 | $3.69M derived: sum of 3 quarters · filed 2025-02-28 | $8.30M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$1.04M 10-Q · filed 2024-05-10 | $1.09M derived: sum of 2 quarters · filed 2025-02-28 | $5.70M derived: sum of 3 quarters · filed 2025-02-28 | $8.42M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.74M derived: sum of 2 quarters · filed 2025-02-28 | $9.46M derived: sum of 3 quarters · filed 2025-02-28 | $15.22M 10-K · filed 2025-02-28 |
| 2022-09-30 | $4.61M 10-Q · filed 2023-11-08 | $7.33M derived: sum of 2 quarters · filed 2023-11-08 | $13.09M 10-Q · filed 2023-11-08 | $14.27M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $2.72M 10-Q · filed 2023-08-09 | $8.48M 10-Q · filed 2023-08-09 | $9.66M derived: sum of 3 quarters · filed 2024-02-29 | $10.86M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $5.77M 10-Q · filed 2023-05-08 | $6.95M derived: sum of 2 quarters · filed 2024-02-29 | $8.14M derived: sum of 3 quarters · filed 2024-02-29 | $7.74M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.38M derived: sum of 2 quarters · filed 2024-02-29 | $1.98M derived: sum of 3 quarters · filed 2024-02-29 | $8.38M 10-K · filed 2024-02-29 |
| 2021-09-30 | $1.20M 10-Q · filed 2022-11-09 | $797.00K derived: sum of 2 quarters · filed 2022-11-09 | $7.20M 10-Q · filed 2022-11-09 | $8.88M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | -$401.00K 10-Q · filed 2022-08-08 | $6.00M 10-Q · filed 2022-08-08 | $7.68M derived: sum of 3 quarters · filed 2023-03-09 | $8.62M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | $6.41M 10-Q · filed 2022-05-10 | $8.08M derived: sum of 2 quarters · filed 2023-03-09 | $9.02M derived: sum of 3 quarters · filed 2023-03-09 | $6.66M derived: sum of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.61M derived: sum of 2 quarters · filed 2023-03-09 | $252.00K derived: sum of 3 quarters · filed 2023-03-09 | -$6.57M 10-K · filed 2023-03-09 |
| 2020-09-30 | $939.00K 10-Q · filed 2021-11-01 | -$1.42M derived: sum of 2 quarters · filed 2021-11-01 | -$8.24M 10-Q · filed 2021-11-01 | -$7.07M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$2.36M 10-Q · filed 2021-08-06 | -$9.18M 10-Q · filed 2021-08-06 | -$8.01M derived: sum of 3 quarters · filed 2022-03-15 | -$9.04M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | -$6.82M 10-Q · filed 2021-05-07 | -$5.65M derived: sum of 2 quarters · filed 2022-03-15 | -$6.68M derived: sum of 3 quarters · filed 2022-03-15 | -$9.49M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $142.00K derived: sum of 2 quarters · filed 2022-03-15 | -$2.67M derived: sum of 3 quarters · filed 2022-03-15 | -$4.49M 10-K · filed 2022-03-15 |
| 2019-09-30 | -$1.02M 10-Q · filed 2020-11-05 | -$3.84M derived: sum of 2 quarters · filed 2020-11-05 | -$5.66M 10-Q · filed 2020-11-05 | -$6.57M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | -$2.81M 10-Q · filed 2020-08-06 | -$4.63M 10-Q · filed 2020-08-06 | -$5.55M derived: sum of 3 quarters · filed 2021-03-11 | -$5.23M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | -$1.82M 10-Q · filed 2020-05-07 | -$2.73M derived: sum of 2 quarters · filed 2021-03-11 | -$2.42M derived: sum of 3 quarters · filed 2021-03-11 | -$2.20M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | -$912.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$595.00K derived: sum of 2 quarters · filed 2021-03-11 | -$379.00K derived: sum of 3 quarters · filed 2021-03-11 | -$379.00K 10-K · filed 2021-03-11 |
| 2018-09-30 | $317.00K 10-Q · filed 2019-11-06 | $533.00K derived: sum of 2 quarters · filed 2019-11-06 | $533.00K 10-Q · filed 2019-11-06 | $533.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $216.00K 10-Q · filed 2019-08-07 | $216.00K 10-Q · filed 2019-08-07 | $216.00K derived: sum of 3 quarters · filed 2020-02-27 | $216.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $0.00 derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |